Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan 1;58(1):109-113.
doi: 10.2169/internalmedicine.0317-17. Epub 2018 Aug 24.

Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome

Kiyohito Hayashi  1 , Taizo Tasaka  1   2 , Toshinori Kondo  1 , Yuichi Ishikawa  3 , Makoto Goto  4 , Yoshiko Matsuhashi  1 , Yoshito Sadahira  5 , Takashi Sugihara  1 , Hideho Wada  1
Affiliations
Case Reports

Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome

Kiyohito Hayashi et al. Intern Med. .

Abstract

Werner syndrome (WS) confers a high risk of the development of neoplasias, including hematological malignancies, and curative treatment for these malignancies is difficult to achieve. A 44-year-old man with myelodysplastic syndrome was admitted to our hospital. He was diagnosed with mutation-proven WS. He underwent cord blood transplantation (CBT) following fludarabine, busulfan, and melphalan administration. A chimerism analysis of his marrow blood on day 62 showed a donor pattern >95%, which confirmed engraftment. The patient lived for 15 months while maintaining remission of MDS without treatment-related toxicity. Our case shows that CBT can be a treatment modality for WS patients with hematological malignancies.

Keywords: Werner syndrome; cord blood transplantation; myelodysplastic syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure.
Figure.
The immunohistochemical expression of p53 and WRN in a formalin-fixed, paraffin-embedded patient bone marrow clot section is shown. The antibody used for the immunostaining reacted with wild-type WRN but not with the mutated WRN of bone marrow erythroblasts. More than 30% of cells were TP53-positive (black arrows) before CBT, but TP53-positive cells were undetectable after CBT. WRN-positive cells (blue arrows) were completely absent before CBT but present after CBT. CBT: cord blood transplantation
See this image and copyright information in PMC

References

    1. Goto M, Miller RW, Ishikawa Y, et al. Exess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5: 239-246, 1996. - PubMed
    1. Ishikawa Y, Sugano H, Matsumoto T, et al. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 85: 1345-1352, 1999. - PubMed
    1. Sugimoto M, Fruichi Y, Ide T, Goto M. Involvement of WRN helicase in immortalization and tumorigenesis by the telomeric crisis pathway (review). Oncol Lett 2: 609-611, 2011. - PMC - PubMed
    1. Björnberg A. Werner’s syndrome and malignancy. Acta Derm Venereol 56: 149-150, 1976. - PubMed
    1. Sato K, Goto M, Nishioka K, et al. Werner’s syndrome associated with malignancies: five case reports with a survey of case histories in Japan. Grontology 34: 212-218, 1988. - PubMed

Publication types

Substances